Results 221 to 230 of about 14,952,911 (382)

Solution of optimal power flow with wind power uncertainty using hybridized self-adaptive differential evolution. [PDF]

Sci Rep
Pulluri H, Devi TA, Kuppireddy NR, Dahiya P, Naga Sai Kalyan C, Goud BS, Shorfuzzaman M, ELrashidi A, Nureldeen W, Reddy CR.   +9 more
europepmc   +1 more source

New mathematical model based on geometric algebra for physical power flow in theoretical two-dimensional multi-phase power circuits. [PDF]

Sci Rep, 2023
Montoya FG, Prado X, Arrabal-Campos FM, Alcayde A, Mira J.   +4 more
europepmc   +1 more source

STATCOM’s contribution to the improvement of voltage plan and power flow in an electrical transmission network

, 2018
Adel Amiar, Mohamed Adjabi
openalex   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Generic optimal power flow solution associated with technical improvements and emission reduction by multi-objective ARO algorithm. [PDF]

Sci Rep
Abaza A, El-Sehiemy RA, Elbarabry Z, Barakat AF.   +3 more
europepmc   +1 more source

The Dynamics of Power Flow From the Global Health Financing Comment on "Power Dynamics Among Health Professionals in Nigeria: A Case Study of the Global Fund Policy Process". [PDF]

Int J Health Policy Manag, 2023
Brown GW, Rhodes N.
europepmc   +1 more source

Preferences for Posttraumatic Osteoarthritis Prevention Strategies in Individuals With Anterior Cruciate Ligament Injury

Arthritis Care &Research, EarlyView.
Objective There is growing interest in evaluating new strategies to delay or prevent posttraumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury. Methods Participants with a history of
Kevin Kennedy, Lily Waddell, Adam Easterbrook, Jeffrey N. Katz, Cale Jacobs, Morgan Jones, Faith Selzer, Elena Losina, Liana Fraenkel, Nick Bansback   +9 more
wiley   +1 more source

A digital twin based forecasting framework for power flow management in DC microgrids. [PDF]

Sci Rep
Sado K, Peskar J, Downey A, Khan J, Booth K.   +4 more
europepmc   +1 more source

Derivative-Free Power Flow Solution for Bipolar DC Networks with Multiple Constant Power Terminals. [PDF]

Sensors (Basel), 2022
Medina-Quesada Á, Montoya OD, Hernández JC.   +2 more
europepmc   +1 more source

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source